Amelioration of Murine Passive Immune Thrombocytopenia by IVIg and a Therapeutic Monoclonal CD44 Antibody Does Not Require the Myd88 Signaling Pathway

• Andrew R. Crow,

  Affiliations Canadian Blood Services, Toronto, Canada, Department of Laboratory Medicine and the Keenan Research Centre in the Li Ka Shing Knowledge Institute of St. Michael’s Hospital, Toronto, Canada

  ⨯
• Honghui Yu,

  Affiliations Canadian Blood Services, Toronto, Canada, Department of Laboratory Medicine and the Keenan Research Centre in the Li Ka Shing Knowledge Institute of St. Michael’s Hospital, Toronto, Canada, Department of Anesthesiology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China

  ⨯
• Dongji Han,

  Affiliations Department of Laboratory Medicine and the Keenan Research Centre in the Li Ka Shing Knowledge Institute of St. Michael’s Hospital, Toronto, Canada, Department of Anesthesiology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China

  ⨯
• Alan H. Lazarus

  * E-mail: lazarusa@smh.ca

  Affiliations Canadian Blood Services, Toronto, Canada, Department of Laboratory Medicine and the Keenan Research Centre in the Li Ka Shing Knowledge Institute of St. Michael’s Hospital, Toronto, Canada, Departments of Medicine and Laboratory Medicine & Pathobiology, University of Toronto, Toronto, Ontario, Canada

  ⨯